204 related articles for article (PubMed ID: 29371111)
1. Globular chitosan prolongs the effective duration time and decreases the acute toxicity of botulinum neurotoxin after intramuscular injection in rats.
Sergeevichev DS; Krasilnikova AA; Strelnikov AG; Fomenko VV; Salakhutdinov NF; Romanov AB; Karaskov AM; Pokushalov EA; Steinberg JS
Toxicon; 2018 Mar; 143():90-95. PubMed ID: 29371111
[TBL] [Abstract][Full Text] [Related]
2. Isolation and Characterization of the Novel Botulinum Neurotoxin A Subtype 6.
Moritz MS; Tepp WH; Bradshaw M; Johnson EA; Pellett S
mSphere; 2018 Oct; 3(5):. PubMed ID: 30355669
[TBL] [Abstract][Full Text] [Related]
3. Botulinum neurotoxin type A-cleaved SNAP25 is confined to primary motor neurons and localized on the plasma membrane following intramuscular toxin injection.
Cai BB; Francis J; Brin MF; Broide RS
Neuroscience; 2017 Jun; 352():155-169. PubMed ID: 28389376
[TBL] [Abstract][Full Text] [Related]
4. How muscles recover from paresis and atrophy after intramuscular injection of botulinum toxin A: Study in juvenile rats.
Shen J; Ma J; Lee C; Smith BP; Smith TL; Tan KH; Koman LA
J Orthop Res; 2006 May; 24(5):1128-35. PubMed ID: 16602109
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin A (Botox) and sweating-dose efficacy and comparison to other BoNT preparations.
Schlereth T; Mouka I; Eisenbarth G; Winterholler M; Birklein F
Auton Neurosci; 2005 Feb; 117(2):120-6. PubMed ID: 15664565
[TBL] [Abstract][Full Text] [Related]
6. Bioprotection of tendon repair: adjunctive use of botulinum toxin A in Achilles tendon repair in the rat.
Ma J; Shen J; Smith BP; Ritting A; Smith TL; Koman LA
J Bone Joint Surg Am; 2007 Oct; 89(10):2241-9. PubMed ID: 17908902
[TBL] [Abstract][Full Text] [Related]
7. Intramuscular injection of 125I-botulinum neurotoxin-complex versus 125I-botulinum-free neurotoxin: time course of tissue distribution.
Tang-Liu DD; Aoki KR; Dolly JO; de Paiva A; Houchen TL; Chasseaud LF; Webber C
Toxicon; 2003 Oct; 42(5):461-9. PubMed ID: 14529727
[TBL] [Abstract][Full Text] [Related]
8. Comparison between botulinum neurotoxin type A2 and type A1 by electrophysiological study in healthy individuals.
Mukai Y; Shimatani Y; Sako W; Asanuma K; Nodera H; Sakamoto T; Izumi Y; Kohda T; Kozaki S; Kaji R
Toxicon; 2014 Apr; 81():32-6. PubMed ID: 24495439
[TBL] [Abstract][Full Text] [Related]
9. Dramatic changes in muscle contractile and structural properties after 2 botulinum toxin injections.
Minamoto VB; Suzuki KP; Bremner SN; Lieber RL; Ward SR
Muscle Nerve; 2015 Oct; 52(4):649-57. PubMed ID: 25598004
[TBL] [Abstract][Full Text] [Related]
10. Intradetrusor botulinum neurotoxin A (BoNT-A) injections decrease bladder fibrosis secondary to partial urethral obstruction in the male rat model.
Tinay I; Tanidir Y; Cikler E; Cetinel S; Tarcan T
Neurourol Urodyn; 2012 Apr; 31(4):564-70. PubMed ID: 22275224
[TBL] [Abstract][Full Text] [Related]
11. Bone and cartilage changes in rabbit mandibular condyles after 1 injection of botulinum toxin.
Matthys T; Ho Dang HA; Rafferty KL; Herring SW
Am J Orthod Dentofacial Orthop; 2015 Dec; 148(6):999-1009. PubMed ID: 26672706
[TBL] [Abstract][Full Text] [Related]
12. Duration and onset of effect of incobotulinumtoxinA for the treatment of blepharospasm in botulinum toxin-naïve subjects.
Mitsikostas DD; Dekundy A; Hanschmann A; Althaus M; Scheschonka A; Pagan F; Jankovic J
Curr Med Res Opin; 2021 Oct; 37(10):1761-1768. PubMed ID: 34384301
[TBL] [Abstract][Full Text] [Related]
13. Motor endplate-targeted botulinum toxin injections of the gracilis muscle in children with cerebral palsy.
Van Campenhout A; Bar-On L; Desloovere K; Huenaerts C; Molenaers G
Dev Med Child Neurol; 2015 May; 57(5):476-83. PubMed ID: 25557985
[TBL] [Abstract][Full Text] [Related]
14. Design of modified botulinum neurotoxin A1 variants with a shorter persistence of paralysis and duration of action.
Scheps D; López de la Paz M; Jurk M; Hofmann F; Frevert J
Toxicon; 2017 Dec; 139():101-108. PubMed ID: 28918229
[TBL] [Abstract][Full Text] [Related]
15. Botulinum Toxin-Chitosan Nanoparticles Prevent Arrhythmia in Experimental Rat Models.
Sergeevichev D; Fomenko V; Strelnikov A; Dokuchaeva A; Vasilieva M; Chepeleva E; Rusakova Y; Artemenko S; Romanov A; Salakhutdinov N; Chernyavskiy A
Mar Drugs; 2020 Aug; 18(8):. PubMed ID: 32748868
[TBL] [Abstract][Full Text] [Related]
16. The clinical utility of botulinum toxin injections targeted at the motor endplate zone in cervical dystonia.
Delnooz CC; Veugen LC; Pasman JW; Lapatki BG; van Dijk JP; van de Warrenburg BP
Eur J Neurol; 2014 Dec; 21(12):1486-e98. PubMed ID: 25060697
[TBL] [Abstract][Full Text] [Related]
17. Characterizing the Bladder's Response to Onabotulinum Toxin Type A Using a Rat Model.
Dieter AA; Wu JM; Siddiqui NY; Degoski DJ; Brooks JM; Dolber PC; Fraser MO
Female Pelvic Med Reconstr Surg; 2016; 22(6):467-471. PubMed ID: 27636215
[TBL] [Abstract][Full Text] [Related]
18. Botulinum Neurotoxin A injections influence stretching of the gastrocnemius muscle-tendon unit in an animal model.
Haubruck P; Mannava S; Plate JF; Callahan MF; Wiggins WF; Schmidmaier G; Tuohy CJ; Saul KR; Smith TL
Toxins (Basel); 2012 Aug; 4(8):605-19. PubMed ID: 23012650
[TBL] [Abstract][Full Text] [Related]
19. Sensorimotor Perceptive Rehabilitation Integrated (SPRInt) program: exercises with augmented movement feedback associated to botulinum neurotoxin in idiopathic cervical dystonia-an observational study.
Castagna A; Caronni A; Crippa A; Sciumè L; Giacobbi G; Corrini C; Montesano A; Ramella M
Neurol Sci; 2020 Jan; 41(1):131-138. PubMed ID: 31478151
[TBL] [Abstract][Full Text] [Related]
20. Extracranial injections of botulinum neurotoxin type A inhibit intracranial meningeal nociceptors' responses to stimulation of TRPV1 and TRPA1 channels: Are we getting closer to solving this puzzle?
Zhang X; Strassman AM; Novack V; Brin MF; Burstein R
Cephalalgia; 2016 Aug; 36(9):875-86. PubMed ID: 26984967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
